Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial

Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20 –30%, and satisfactory treatment is obtained in 40–60% of pat...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Research Source Type: research